In recent years, with the acceleration of drug approval, the promotion of consistency evaluation of generic drugs, the procurement of drugs, the adjustment of medical insurance catalogues and other new pharmaceutical policies, the transformation and upgrading of China's pharmaceutical industry has accelerated, and the biopharmaceutical industry represented by monoclonal antibodies, bispecific antibodies and ADCs has flourished, bringing new opportunities and challenges
to the upstream pharmaceutical equipment industry.
Since 2020, domestic pharmaceutical machines have seized the huge space for import substitution, and their market share has gradually increased
.
So, how will China's pharmaceutical equipment market develop in the next few years? What are the trends?
How will the pharmaceutical equipment industry develop in the future? Four trends have long been known (Image source: Pharma.
com)
According to the public data of listed pharmaceutical equipment, we can see that in the past two years, the performance of pharmaceutical machinery enterprises represented by Chutian Science and Technology, Dongfulong and other heads in China has achieved steady growth, and the overall prosperity of the industry is relatively high
.
The main reason for this situation is the surge in orders brought about by the demand for vaccine equipment, the pull of upstream biological drugs, and the import substitution brought about by the epidemic, and the domestic head with advantages has seized the opportunity
.
For how long this situation can be maintained, some institutions predict that in the post-epidemic era, domestic pharmaceutical machine enterprises can still maintain certain growth by virtue of the advantages of performance improvement, good service level, and convenient maintenance, at the same time, under the rapid development of the biopharmaceutical industry, the demand for bioreactors and other equipment is also expected to continue to expand, and there is room for
import substitution.
In addition, the aging of the population will bring growth effects
to the entire pharmaceutical industry, including the upstream.
In general, there are still opportunities in China's pharmaceutical equipment industry, and the next few years will usher in a long-term growth
under the impetus of a series of favorable factors.
The main industry development trends may include the following aspects:
Trend 1, the domestic pharmaceutical equipment market will undergo tremendous changes
.
At present, China's pharmaceutical equipment enterprises are mainly based on the supply of single equipment, and today's market demand is more and more focused on efficient production, cost control, and reducing land occupation, so the number of suppliers that can provide overall solutions will gradually increase
in the future.
Trend two, the development model of pharmaceutical equipment enterprises will change
.
In the past, China's pharmaceutical machinery enterprises mostly adopted an extensive development model, which brought problems such as waste of resources and excessive costs, and the overall development level of enterprises was low
.
Therefore, in the future, the business model of pharmaceutical machinery enterprises will change, and it will change
from extensive to lean management.
Trend three, pharmaceutical equipment will be more "intelligent"
.
Nowadays, under the goal of cost reduction and efficiency increase, intelligence has become the development direction of the pharmaceutical equipment industry, through updating and upgrading, pharmaceutical equipment can achieve good intelligent control and remote monitoring control, operators can analyze and process the system online, and independently complete some steps or processes
.
At present, the state has also introduced encouragement and support policies related to promoting intelligent manufacturing, and it is expected that the combination of intelligent production lines and unit operation process equipment for pharmaceutical equipment will become the general trend
in the future.
Trend four, pharmaceutical equipment with high energy consumption and backward performance will be eliminated at an accelerated pace
.
At present, in the process of modernization, China's pharmaceutical companies are more and more inclined to intelligent, energy-saving and consumption-reducing high-end equipment, and some traditional equipment with weak performance and large energy consumption is no longer needed
.
In the future, pharmaceutical equipment enterprises will only be competitive
if they continue to innovate and upgrade.
In addition, how to better improve the performance of domestic equipment, break the bottleneck of core "stuck neck" technology, and catch up with imported high-end equipment is also worthy of deep reflection and exploration
in the industry.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"Share to:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
